FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Dextrose Monohydrate 50% Injection
Status: Currently in Shortage
»Date first posted: 01/13/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc. (Reverified 08/06/2026)

Company Contact Information:
800-423-4136

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)	Available

Hospira, Inc., a Pfizer Company (Revised 08/07/2026)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)	Available
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-4902-34)	Unavailable	Discontinuation of the manufacture of the drug Link to Discontinuation	Discontinuation of the manufacture of the drug
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02)	Limited Availability	Next Delivery: October 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay	Other